Arquivos Brasileiros de Endocrinologia & Metabologia
versão impressa ISSN 0004-2730
WEINERT, Letícia Schwerz et al. Is there a role for inherited TR βmutation in human carcinogenesis?. Arq Bras Endocrinol Metab [online]. 2012, vol.56, n.1, pp. 67-71. ISSN 0004-2730. http://dx.doi.org/10.1590/S0004-27302012000100010.
Resistance to thyroid hormone (RTH) is a rare autosomal dominant inherited disorder characterized by end-organ reduced sensitivity to thyroid hormone. This syndrome is caused by mutations of the thyroid hormone receptor (TR) β gene, and its clinical presentation is quite variable. Goiter is reported to be the most common finding. A close association of TRβ mutations with human cancers has become apparent, but the role of TRβ mutants in the carcinogenesis is still undefined. Moreover, higher TSH levels, described in RTH syndrome, are correlated with increased risk of thyroid malignancy, whereas TSH receptor stimulation is likely to be involved in tumor progression. We report here an illustrative case of a 29 year-old patient with RTH caused by a mutation in exon 9 (A317T) of TRβ gene, who presented multicentric papillary thyroid cancer. We review the literature on this uncommon feature, and discuss the potential role of this mutation on human tumorigenesis, as well as the challenges in patient follow-up.